We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cigna's (CI) Evernorth Launches Value-Based Care Program
Read MoreHide Full Article
The Cigna Group’s (CI - Free Report) Evernorth Health Services recently announced an innovative measurement-based care program to improve behavioral health outcomes. This will help it deliver better care to its provider network with active collaboration and create better, meaningful, and standard metrics for behavioral healthcare.
This move bodes well for Evernorth as it would improve health outcomes of patients in the provider network and help with client retention. Evernorth Health Services segment aims to bring value or measurement-based care to behavioral health, which has existed for a long time in physical health. As providers and payers continue their journey toward value-based care, programs to improve the quality of care and reduce administrative costs should poise Cigna’s Evernorth well for growth. The company expects the Evernorth Health Services segment to report adjusted operating income on a pretax basis of a minimum of $6.4 billion in 2023.
Through this initiative, Evernorth will strengthen its interventions with patients and improve its relationship with providers. A lack of consistent and repeatable measures marks this program as a time opportune one, as this would reduce administrative work and ensure trust from providers. This new program aims to align the measurement of treatments, improving quality of care while reducing costs. Collaborating with providers and establishing measurement touchpoints would benefit patients and clients as well as solidify Evernorth’s core value proposition.
Evernorth will work with 44,000 providers, including behavioral health coaches, therapists etc, and build on its existing metrics, like the time taken for a patient to get an appointment, to ensure high-quality care is provided. Tracking such information will aid providers in focusing on patient care and improve outcomes for patients and providers. Shared metrics can be used by providers and payers to get insights into a patient’s journey and improve the value-based care provided.
Shares of Cigna have gained 8.7% in the past six months compared with the industry’s 1.4% growth. CI currently carries a Zacks Rank #3 (Hold).
The Zacks Consensus Estimate for Select Medical’s 2023 earnings indicates a 56.9% year-over-year increase to $1.93 per share. It has witnessed one upward estimate revision in the past 60 days against no movement in the opposite direction. The consensus mark for SEM’s 2023 revenues indicates 4.2% growth from a year ago.
The Zacks Consensus Estimate for HCA Healthcare’s 2023 bottom line suggests a 9.4% increase from the prior-year levels. HCA has witnessed one upward estimate revision in the past week against none in the opposite direction. It beat earnings estimates in three of the last four quarters and missed once, with the average surprise being 5.4%.
The Zacks Consensus Estimate for Atai Life Sciences’ current-year earnings implies a 16.3% improvement from the year-ago reported figure. It has witnessed four upward estimate revisions in the past 60 days against no movement in the opposite direction. ATAI beat earnings estimates in two of the last four quarters, met once and missed on one occasion.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Cigna's (CI) Evernorth Launches Value-Based Care Program
The Cigna Group’s (CI - Free Report) Evernorth Health Services recently announced an innovative measurement-based care program to improve behavioral health outcomes. This will help it deliver better care to its provider network with active collaboration and create better, meaningful, and standard metrics for behavioral healthcare.
This move bodes well for Evernorth as it would improve health outcomes of patients in the provider network and help with client retention. Evernorth Health Services segment aims to bring value or measurement-based care to behavioral health, which has existed for a long time in physical health. As providers and payers continue their journey toward value-based care, programs to improve the quality of care and reduce administrative costs should poise Cigna’s Evernorth well for growth. The company expects the Evernorth Health Services segment to report adjusted operating income on a pretax basis of a minimum of $6.4 billion in 2023.
Through this initiative, Evernorth will strengthen its interventions with patients and improve its relationship with providers. A lack of consistent and repeatable measures marks this program as a time opportune one, as this would reduce administrative work and ensure trust from providers. This new program aims to align the measurement of treatments, improving quality of care while reducing costs. Collaborating with providers and establishing measurement touchpoints would benefit patients and clients as well as solidify Evernorth’s core value proposition.
Evernorth will work with 44,000 providers, including behavioral health coaches, therapists etc, and build on its existing metrics, like the time taken for a patient to get an appointment, to ensure high-quality care is provided. Tracking such information will aid providers in focusing on patient care and improve outcomes for patients and providers. Shared metrics can be used by providers and payers to get insights into a patient’s journey and improve the value-based care provided.
Shares of Cigna have gained 8.7% in the past six months compared with the industry’s 1.4% growth. CI currently carries a Zacks Rank #3 (Hold).
Image Source: Zacks Investment Research
Stocks to Consider
Some better-ranked stocks in the medical space are Select Medical Holdings Corporation (SEM - Free Report) , HCA Healthcare, Inc. (HCA - Free Report) and Atai Life Sciences N.V. (ATAI - Free Report) . While Select Medical sports a Zacks Rank #1 (Strong Buy), HCA Healthcare and Atai Life Sciences carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Select Medical’s 2023 earnings indicates a 56.9% year-over-year increase to $1.93 per share. It has witnessed one upward estimate revision in the past 60 days against no movement in the opposite direction. The consensus mark for SEM’s 2023 revenues indicates 4.2% growth from a year ago.
The Zacks Consensus Estimate for HCA Healthcare’s 2023 bottom line suggests a 9.4% increase from the prior-year levels. HCA has witnessed one upward estimate revision in the past week against none in the opposite direction. It beat earnings estimates in three of the last four quarters and missed once, with the average surprise being 5.4%.
The Zacks Consensus Estimate for Atai Life Sciences’ current-year earnings implies a 16.3% improvement from the year-ago reported figure. It has witnessed four upward estimate revisions in the past 60 days against no movement in the opposite direction. ATAI beat earnings estimates in two of the last four quarters, met once and missed on one occasion.